Abstract

Extensive heterogeneity in autism spectrum disorder (ASD) has hindered the characterization of consistent biomarkers, which has led to widespread negative results. Isolating homogenized subtypes could provide insight into underlying biological mechanisms and an overall better understanding of ASD. A total of 1093 participants from the population-based “Healthy Brain Network” cohort (Child Mind Institute in the New York City area, USA) were selected based on score availability in behaviors relevant to ASD, aged 6–18 and IQ >= 70. All participants underwent an unsupervised clustering analysis on behavioral dimensions to reveal subgroups with ASD traits, identified by the presence of social deficits. Analysis revealed three socially impaired ASD traits subgroups: (1) high in emotionally dysfunctional traits, (2) high in ADHD-like traits, and (3) high in anxiety and depressive symptoms. 527 subjects had good quality structural MRI T1 data. Site effects on cortical features were adjusted using the ComBat method. Neuroimaging analyses compared cortical thickness, gyrification, and surface area, and were controlled for age, gender, and IQ, and corrected for multiple comparisons. Structural neuroimaging analyses contrasting one combined heterogeneous ASD traits group against controls did not yield any significant differences. Unique cortical signatures, however, were observed within each of the three individual ASD traits subgroups versus controls. These observations provide evidence of ASD traits subtypes, and confirm the necessity of applying dimensional approaches to extract meaningful differences, thus reducing heterogeneity and paving the way to better understanding ASD traits.

Details

Title
Cortical signatures in behaviorally clustered autistic traits subgroups: a population-based study
Author
Mihailov Angeline 1   VIAFID ORCID Logo  ; Philippe, Cathy 1   VIAFID ORCID Logo  ; Gloaguen Arnaud 2 ; Grigis Antoine 1 ; Laidi, Charles 3 ; Piguet Camille 4 ; Houenou Josselin 3   VIAFID ORCID Logo  ; Frouin Vincent 1   VIAFID ORCID Logo 

 Université Paris-Saclay, Neurospin, Institut Joliot, CEA, Gif-sur-Yvette, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535) 
 Université Paris-Saclay, Neurospin, Institut Joliot, CEA, Gif-sur-Yvette, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535); 3 rue Joliot-Curie, CNRS-Centrale Supélec, Gif-sur-Yvette, France (GRID:grid.460789.4) 
 Université Paris-Saclay, Neurospin, Institut Joliot, CEA, Gif-sur-Yvette, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535); University of Paris-Est Créteil, APHP, Mondor Univ. Hospitals, DMU IMPACT, INSERM, U955, Translational Neuropsychiatry Team, Créteil, France (GRID:grid.460789.4) 
 Université Paris-Saclay, Neurospin, Institut Joliot, CEA, Gif-sur-Yvette, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535); University of Geneva, Faculty of Medicine, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2322 4988) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2487258865
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.